• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 40X1; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 40X1; BONE CEMENT, ANTIBIOTIC Back to Search Results
Catalog Number 4003940001
Device Problems Unsealed Device Packaging (1444); Incomplete or Missing Packaging (2312)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/25/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).(b)(6).The device has been returned to the manufacturer.After evaluation it has been seen that the inner sterile packaging was damaged.The packaging missing event could not been confirmed.Indeed, the device history record has been reviewed.No discrepancies were found.With the available information, the exact root cause of the event could not be determined.However, a corrective action has been initiated to address the damaged inner sterile packaging issue.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that the aluminium pouch was missing.There was no patient injury and no delay in the surgery.However, after product reception and evaluation on 25 june 2018, it has been discovered that the inner sterile packaging was damaged.
 
Manufacturer Narrative
(b)(4).Complaint sample was evaluated and the reported event was confirmed.Evaluation of returned device found the supplier sealing was opened in 1 area.The manufacture sealing was intact.Device history record (dhr) was reviewed and no discrepancies were found.Investigation results concluded that the reported event was due to product design.Corrective action has been initiated to address reported issue.The missing packaging event described in the complaint was investigated, and this event could not be confirmed.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
Please refer to 3006946279-2018-00231.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 40X1
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key7771728
MDR Text Key116708402
Report Number3006946279-2018-00231
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
PMA/PMN Number
PK150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Remedial Action Modification/Adjustment
Type of Report Initial,Followup
Report Date 01/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2019
Device Catalogue Number4003940001
Device Lot NumberA702AB0707
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/21/2018
Was the Report Sent to FDA? No
Date Manufacturer Received06/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-